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ABSTRACT
Photodynamic therapy (PDT) has become a widely popular therapeutic approach
for treating various types of cancer over the past several decades. PDT utilizes a
photosensitizer, visible light, and oxygen, to produce reactive oxygen species (ROS)
which can be used to treat cancer and inhibit growth of bacteria. In this study, a
multifunctional solution that is comprised of Fe(III) ions, cationic meso-tetra(N-methyl4-pyridyl)porphine tetrachloride (TMPyP), and 1,5-dihydroxynapthalene (1,5-DHN), was
shown to produce reactive oxygen species (ROS) such as singlet oxygen (1O2) or
hydroxyl radicals (ȮH) in aerobic or anaerobic environments, respectively, and in both
environments, 1,5-DHN was oxidized to Juglone or derivatives of Juglone. Moreover,
this multifunctional solution was found to generate ȮH and Juglone in a hydrogen
peroxide (H2O2) rich environment without the presence of visible light. This
multifunctional solution has shown potential as a possible antibacterial agent and
photosensitizer for PDT which possesses unique characteristics that can address many of
the limitations and challenges in the field of PDT.
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CHAPTER 1

Introduction
As deaths due to cancer are increasing, researchers all around the world are
working towards developing newer and more efficient therapeutic methods to treat
cancer. Current cancer treatments include chemotherapy, radiation, and surgery which are
limited because of their lack in selectivity of removing or killing tumors.1 Newer
treatment methods such as photodynamic therapy (PDT) can treat various types of
cancers and is accepted as an effective and noninvasive treatment method.2 PDT requires
three components in order to be effective which are visible light, a photosensitizer, and
dissolved oxygen. A photosensitizer can react with visible light and transfer energy to
nearby dissolved oxygen (O2) which will generate singlet oxygen (1O2). Singlet oxygen is
a type of reactive oxygen species (ROS) and is a key component in killing cancer cells.3-4
Although PDT shows promise in treating cancer, there are currently a few limitations to
this therapeutic method. Firstly, the photosensitizer must be soluble in bodily tissue so
that the photosensitizer can have sufficient localization to the tumor. Secondly, many
large tumors that are in deeper tissues must be able to be penetrated by visible light or
there will be no activation of the photosensitizer. Lastly, if a tumor that has become
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hypoxic due to improper supply of blood, then PDT becomes ineffective since the
therapy requires the presence of oxygen for producing singlet oxygen.5-7 Thus, to have
effective therapeutic capability, there has been an increased interest in finding appropriate
compounds that can address one or more of the limitations that PDT can experience.
A possible photosensitizer, that has become increasingly used in PDT to treat
various types of cancers is a porphyrin called meso-tetra(4-N-methylpyridyl)porphine
(TMPyP).8 TMPyP is a cationic porphyrin with four nitrogen atoms at the center of the
molecule that can chelate various divalent metals. This molecule is also conjugated with
double bonds which provides stability. A few characteristics that makes TMPyP a unique
photosensitizer for PDT is that it is a water-soluble porphyrin and has the ability to be
soluble in physiological liquids. Moreover, TMPyP requires no synthesis and can be
acquired as a chemically pure and stable compound. In addition, TMPyP also has the
capability of generating a high yield of singlet oxygen (ΔΦ = 0.70 in phosphate-buffered
solution).9 Although this photosensitizer can address one of the limitations of PDT, it
fails to produce ROSs in a hypoxic environment which is one of the major limitations of
PDT. However, an advantage of TMPyP is that it has emissions in the red region and
researchers can use this emission to study the localization of TMPyP. Villanueva and
Patito, et al reported that TMPyP, at low concentrations, enters the cells via endocytosis
and collects into lysosomes. Upon irradiation with visible light, ROS are produced which
destroys the lysosome, distributing TMPyP into the nucleus and binding itself with
DNA.10
2

Even with the excellent properties and characteristics of TMPyP, it is still unable
to independently address the limitations of tumor hypoxia and the possibility of large
tumors being impenetrable by visible light. To bypass the multiple limitations of PDT,
another molecule or compound must be used in combination with TMPyP to create an
effective treatment solution. Metals for example have been reported in the literature to be
used as metal-based drugs for treating cancer. Cisplatin is a commonly known metalbased drug that has seen some success. However, these types of drugs face many
challenges such as fatal side effects and poor water solubility and so more research in this
area is needed to make further advancements.11 In other research attempts, scientists have
attempted to utilize unique, specific characteristics of cancer cells as a target for new
therapeutic techniques. For instance, a specific characteristic of cancer cells is that they
produce more hydrogen peroxide than normal cells.12-13 By taking advantage of the
increased hydrogen peroxide produced from cancer cells, researchers can use iron-based
methods to produce ROS via the Fenton reaction to kill those same cancer cells. For this
reaction, Fe(II) ions can decompose hydrogen peroxide into hydroxyl radicals which are
capable of damaging proteins, lipids, and DNA which leads to cell death.14-16 Although
this is a feasible method, the Fenton reaction forms iron-containing sludge (Fe(OH)3) as
the reaction progresses which can lower the capability of producing hydroxyl radicals.17
For this project, an attempt is made to address several of PDT’s limitations by
studying a multifunctional system that is comprised of cationic meso-tetra(N-methyl-4pyridyl)porphine tetrachloride (TMPyP), 1,5-dihydroxynapthalene (1,5-DHN), and
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Fe(III) ions which is not coordinated to the porphyrin ring (Figure 1). This treatment
composition under visible light irradiation and aerobic environment produces, in situ,
singlet oxygen, hydroxyl radical, and Juglone or its derivatives (non-toxic
chemotherapeutic drugs). Furthermore, in an anaerobic environment, with visible light
irradiation, the treatment composition is still able to produce hydroxyl radicals and
Juglone or its derivative. Moreover, utilizing the increased hydrogen peroxide
characteristic of cancer cells, the treatment composition undergoes a Fenton-like reaction
which generates O2 and hydroxyl radicals from hydrogen peroxide. This Fenton-like
reaction is advantageous because no visible light is required for the production of
hydroxyl radicals from hydrogen peroxide. This is a potential way to treat tumors that are
deep in tissues and are unable to be penetrated by visible light. Moreover, the oxygen that
is generated from the Fenton-like reactions can also be useful in situations of tumor
hypoxia. With oxygen now being produced from the Fenton-like reactions, the
photosensitizer can transfer its energy to oxygen and generate singlet oxygen under
visible light conditions which is not possible without oxygen present. Lastly, using
Fe(III) ions for the Fenton-like reaction does not produce an iron-containing sludge
(Fe(OH)3), so the production of hydroxyl radicals is not reduced. This treatment
composition was also tested against E. coli in an aerobic environment with the presence
and absence of visible light which showed some inhibition of growth. These results
indicate that this multifunctional treatment solution can potentially treat bacteria and
shows potential for treating cancer cells.
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Figure 1. Structures for Fe(III)TMPyP, TMPyP, DHN, and Juglone.
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CHAPTER 2

Methods and Materials
Materials, Chemicals, and Stock Preparation
Ultrapure H2O (18.2 MΩ) was obtained from a U.S. Filter Corporation
deionization system. Meso-tetra(N-methyl-4-pyridyl)porphine tetrachloride (TMPyP) and
Fe(III)TMPyP were purchased from Frontier Scientific Inc., USA. 1,5Dihydroxynapthalene (DHN) and 5-hydroxy-1,4-naphthalenedione (Juglone) were
received from Acros Organics. Iron (II) chloride and Iron (III) chloride were obtained
from Flinn Scientific Inc., USA. Singlet oxygen sensor green (SOSG) was purchased
from ThermoFisher Scientific Co., USA. 2-propanol was purchased from VWR
analytical, USA, while p-nitrophenol, D2O, NaN3, and methylene blue were purchased
from Sigma Aldrich, USA, these chemicals were used as received and no purification
was needed. UV-vis spectra were recorded by using an Agilent 8453 single beam diode
array spectrometer (Agilent Technologies, USA, model 8453). Fluorescence spectra
were recorded by using a Perkin-Elmer LS-55, Fluorescence Spectrometer (PerkinElmer, USA) at room temperature. All the experiments requiring visible light irradiation
were carried out on a Rayonet Chamber Reactor equipped with sixteen 5750Å lamps
(The Southern New England Ultraviolet Co, USA, model RPR-100). A blue CW laser
6

(447 nm, 20 mW, 2.0 mm beam diameter), green CW laser (532 nm, 20 mW, 2.0 mm
beam diameter), and CW laser (655 nm, 100 mW, Model: MRL-III-655-100mW
15060452) were purchased from Dragon Lasers CO, China.
TMPyP, Fe(III) ions, and DHN Standard Mixture Preparation
A standard solution of TMPyP (1.0 × 10-3 M), iron (III) chloride (1.0 × 10-2 M),
and iron (II) chloride (1.0 × 10-2 M) were prepared in ultra-pure H2O at room temperature
under normal atmospheric conditions. The DHN (1.0 × 10-2 M) stock solution was
prepared in a CH3CN:H2O (9:1, v/v) mixture solvents at room temperature. For a
conventional experimental solution, 30 μL of 1.0 × 10-2 M Fe(III) ions and 36 μL of 1.0 ×
10-2 M DHN was mixed in a cuvette with 3 mL of TMPyP at 6.00 × 10-6 M. Normally, a
Quartz cuvette was used with a 1 cm path-length and volume of 3 mL for all
measurements.
Photooxidation of 1,5-dihydroxynaphthalene (DHN) by TMPyP in Aqueous
Solution.
A 3 mL experimental solution containing DHN, at 1.2 × 10-4 M, and TMPyP, at
6.0 × 10-6 M, was prepared by mixing 36 µL of 1 × 10-2 M of DHN and 18 µL of 1 × 10-3
M of TMPyP with ultrapure water and normal atmospheric and room temperature
conditions. The solution was irradiated with visible light in a Rayonet photoreactor for
approximately twenty minutes at 28 °C. After every 2 minutes, the degradation of DHN
was monitored by recording its decrease in absorption at 301 nm through UV-vis
spectroscopy. The effect of metal ions on singlet oxygen generation was studied similarly
7

except with the addition of 30 μL amounts of M2+ ions (1 × 10-2 M) into a DHN/TMPyP
aqueous solution.
Singlet Oxygen (1O2) Detection.
A 5 mM stock solution of SOSG was prepared by adding 33 μL of methanol to
the 100 μg of SOSG sample. For each experiment, 6 μL of SOSG stock solution was
placed into 3 mL of aqueous solution of TMPyP at 6.0 × 10-6 M. This sample solution
was irradiated with a 532 nm CW laser and the fluorescence emission at 525 nm was
recorded to monitor the production of singlet oxygen every 10 mins for a duration of 60
mins. (Fluorescence emission parameters are as follows: excitation at 504 nm, excitation
slit 5 nm, emission slit 7 nm, speed 1000 nm/min, and a gain of medium.)
Singlet Oxygen Quantum Yield (ΦΔ) of TMPyP.
The singlet oxygen quantum yield of TMPyP was determined using DHN at a
concentration of 1.2 × 10-4 M as a singlet oxygen quencher and methylene blue (MB) as
a reference standard. A 3 mL solution of TMPyP, at 6.0 × 10-6 M, and MB, at 1.0 × 10-5
M, were prepared. Each solution contained DHN at 1.2 × 10-4 M. Then, each solution
was irradiated with a 655 nm CW laser and the UV-vis spectrum of the solution was
recorded for 5 minutes at 1-minute intervals. The quantum yields were calculated with
equation 1 by using known ΦΔ(s) of MB (ΦΔ=0.52).18-19
Fluorescence Quantum Yield of TMPyP Using Crystal Violet as Known Standard
The experimental procedure for the fluorescence quantum yield of the TMPyP at
a concentration of 6.0 × 10-6 M was followed using standard method described in
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literature.18,20 Crystal violet (1.0 × 10-5 M) has a known fluorescence quantum yield (ΦF)
of 0.020 in water and was used as a standard.21
In vitro Effects of TMPyP with BL21 E. coli
To test the effects of singlet oxygen, BL21 E. coli cells were subjected to various
combinations of aqueous solutions of TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M),
Juglone (1.2 × 10-4 M), and iron (III) (1.0 × 10-4 M). The experimental group was
subjected to the aqueous solutions while the control group was only contained sterile
water. E. coli cell cultures were grown using reported literature protocol.22 In short, a
colony of E. coli was allowed to grow overnight in Luria Broth (LB) in an incubator at
28oC and shaking at 250 rpm until the beginning of their exponential growth phase (A600
= 0.2). For each experiment, one milliliter aliquots of the E. coli solution were placed in
microcentrifuge tubes and centrifuged. The resulting tube contained the E. coli pellet and
the supernatant. A micropipette was used to remove the supernatant and keep the pellet as
much as possible. The pellet was then resuspended with 500.0 μL of sterile water. This
process of centrifugation and removing of the supernatant was repeated. For each tube,
either 200 μL of experimental stock solutions was added or 200 μL of sterile water was
added as a control. Experimental and control groups were either subjected to 10 minutes
of irradiation of visible light via the Rayonet photoreactor or covered and kept in dark for
10 minutes. After 10 minutes, the 700.0 μL tubes were vortexed and 20.0 μL of each
sample was spread evenly over individual petri dishes containing LB agar. The plates
were inverted then incubated at 28oC for 48 hours. The observed results reported are from
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the effects of the multifunctional treatment composition or the individual components of
the composition. These results are to visually, not quantitatively, see the effectiveness of
the drug’s inhibition of E. coli cells.
Fluorescence Studies of TMPyP in combination with DHN and Fe(III) ions.
Three different solution samples of 3 mL were prepared to study its fluorescence
ability. The first sample contained only a solution of TMPyP which was prepared by
mixing 18 μL of 1.0 × 10-3 M TMPyP with ultrapure water. The second solution
composed of TMPyP, in combination with Fe(III) ions which was prepared by mixing 30
μL of 1.0 × 10-2 M iron (III) with 18 μL of 1.0 × 10-3 M TMPyP in ultrapure water. The
last solution was prepared by mixing 36 μL of 1.0 × 10-2 M DHN and 18 μL of 1.0 × 10-3
M TMPyP in ultrapure water. Fluorescence emission was measured upon excitation of
each solution at 423 nm with an excitation slit width of 10.0 nm and an emission slit
width of 12.0 nm. Each experiment was carried out at room temperature and under
normal atmospheric conditions.
The Optimization of Hydrogen Peroxide’s Concentration by Oxidation of DHN.
Eight vials of equal amounts of TMPyP (6.0 × 10-6 M), Fe(III) ions (1.0 × 10-4
M), and DHN (1.2 × 10-4 M) solutions were prepared by mixing required amounts of
TMPyP, Fe(III) ions, and DHN with ultrapure water at room temperature and under
normal atmospheric conditions. Different micromolar (µM) amounts of H2O2 were added
to each vial and was left in dark for about 3 minutes. A UV-vis spectrum was taken for
each sample before the hydrogen peroxide was added and after 3 minutes of adding the
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hydrogen peroxide. The oxidation of DHN was used as measure of finding the optimized
concentration of hydrogen peroxide. The following concentrations of hydrogen peroxide
were used to find the optimum concentration: 50 μM, 75 μM, 100 μM, 125 μM, 150 μM,
300 μM, 400 μM, and 500 μM.
Effects of DHN Oxidation by Optimized Hydrogen Peroxide and Varying Fe(III)
Ion Concentrations.
Seven vials of equal amounts of TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and
H2O2 (400 × 10 -6 M) were prepared by mixing required amounts of TMPyP, Fe(III) ions,
DHN, and H2O2 with ultrapure water at room temperature and under normal atmospheric
conditions. Various amounts of Fe(III) ions, ranging from 0.10 mM to 1.0 µM, was added
to the solution and was left in the dark for about 3 minutes. A UV-vis spectrum was taken
for each sample before the hydrogen peroxide was added and after 3 minutes of adding
the hydrogen peroxide. The oxidation of DHN was used as a measure of finding the
effects of varying the concentration of Fe(III) ions. For each of the eight solutions, the
following concentrations of Fe(III) ions were added: 1.00 × 10-4 M, 2.25 × 10-5 M, 2.00 ×
10-5 M, 1.75 × 10-5 M, 1.50 × 10-5 M, 1.00 × 10-5 M, and 1.00 × 10-6 M.
MCF-7 Cell Culture
MCF-7 cells were purchased from ATCC (American Type Culture Collection)
and maintained in 5% DMSO at -80ºC until needed for use. For culture, cells were
maintained in RPMI 1460 Medium (Gibco, CA) enriched with 10% FBS (Fetal Bovine
Serum) and 1% antibiotic/antimycotic at 37ºC with 5% CO2 in a humidified atmosphere.
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Treatment of MCF-7 Cells
MCF-7 cells were seeded at 10,000 cells per well in a 96 well plate. Cells were
left in a humidified atmosphere at 37ºC with 5% CO2 to attach for 24 hours. The cells
were treated with 6.0 ×10-6 M of TMPyP, 1.2 ×10-4 M of DHN, and 1.0 ×10-4 of Fe(III)
ions. There were also conditions of TMPyP and DHN, TMPyP and Fe, and TMPyP,
DHN, and Fe. After treatment, the group of the cells was irradiated with visible light for
10 minutes using a Rayonet photoreactor. The other experimental group was not
irradiated with visible light and was placed in a dark environment for 10 minutes.
Using MTS Assay for Determining Cell Viability
After treatment in visible light or dark conditions, a viability assay was carried
out. Manufacturer’s (Promega) instructions were followed. In short, 20 µl of MTS
solution was added to the media of each well and incubated for 4 hours. The plates were
read at 492 nm using a SkanIt plate reader. This was also done after 24 and 48 hours of
visible light or dark reactions.
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CHAPTER 3

Results and Discussion

Generation of Singlet Oxygen (1O2), Hydroxyl radical (ȮH), and Juglone by the
Multifunctional Treatment Composition Through Visible Light Irradiation and
Aerobic Conditions
To directly detect the generation of singlet oxygen (1O2) from TMPyP, a chemical
called singlet oxygen sensor green (SOSG) was used. SOSG is a reagent used for
detecting singlet oxygen and does not show response to other ROS such as hydroxyl
radicals or superoxide anions. SOSG was added to an aqueous solution of TMPyP and
was irradiated with visible light at 532 nm. In the presence of singlet oxygen, SOSG
emits a green fluorescence. Figure 2 shows the fluorescence intensity of SOSG. With
increased length of visible light irradiation, there is a gradual increase in the intensity of
fluorescence which indicates the generation of singlet oxygen in aqueous solution.23 Each
spectrum shown in Figure 2 was recorded immediately after 10 minutes of irradiation
with a 532 nm light which continued up to 60 minutes of irradiation. Figure 2b shows the
emission intensity of SOSG at 525 nm which gradually increased after 60 minutes of
irradiation with the 532 nm light. Additional similar experiments were conducted to
ensure the presence of singlet oxygen. For example, the emissions intensity of SOSG
13

greatly increased in D2O solvent compared to H2O. In contrast, a physical singlet oxygen
quencher, NaN3, was used which showed that the fluorescence emission intensity
significantly decreased. This data indicates that TMPyP is sufficient at generating singlet
oxygen in an aqueous environment which suggests that TMPyP has capabilities of being
a photosensitizer.

Figure 2: (a) The emissions plot for TMPyP (6.0 × 10-6 M) and SOSG in aqueous
solution with a 532 nm laser for irradiation. Each curve represents length of irradiation
with the laser: no irradiation time (blue); 10 minutes of irradiation (orange); 20 minutes
(grey); 30 minutes (yellow); 40 minutes (light blue); 50 minutes (green); and 60 minutes
(purple). (b) The SOSG peak at 525 nm after 60 minutes of irradiation by the 532 nm
laser while recording the fluorescence spectra every 10 minutes. The following
parameters for the spectrometer are as follows: Ex WL:423 nm; Start:433nm; End:800
nm; Ex Slit:10.0 nm; Em Slit:12.0 nm; Speed:1000 nm/min; Gain: High; Auto Lamp: on
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TMPyP was also tested for its efficiency in generating singlet oxygen in an
aqueous solution. Singlet oxygen quantum yield (ΦΔ) was calculated by using methylene
blue which has a known singlet oxygen yield of 0.52.24 As a chemical probe to detect
singlet oxygen in solution, 1,5-dihydroxynapthalene (1,5-DHN) was used for the
experiment. The reaction of 1,5-DHN and singlet oxygen is considered a fast reaction
that forms Juglone as its primary product (Scheme 1).25 The reaction is monitored by
observing a steady decrease of the absorption of 1,5-DHN peaks at 295 nm to 355 nm.
1,5-DHN’s ability as a singlet oxygen probe is needed for the singlet oxygen quantum
yield measurement. Equation 1 shows how the singlet oxygen quantum yield was
calculated for TMPyP.

𝛷∆(𝑥) = 𝛷∆(𝑠) ×

𝑆𝑥 𝐹𝑠
×
𝑆𝑠 𝐹𝑥

𝐸𝑞. 1

The S represents the slope of the plot of the absorbance vs irradiation and where F is the
absorption correction factor. The singlet oxygen quantum yield of TMPyP was calculated
to be 0.503. This value is lower than the 0.58 which was calculated by Gensch et al.26
Other researchers have reported higher singlet oxygen quantum yields for TMPyP such as
0.7427 and 0.9.28
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Scheme 1. The photooxidation of DHN to Juglone by reacting with singlet oxygen in the
presence of TMPyP under visible light irradiation in aerobic conditions.

Scheme 1 depicts the photooxidation of 1,5-DHN by singlet oxygen to
predominantly produce Juglone which is 5-hydroxy-1,4-naphthoquinone, a natural
compound found in walnuts.25,29 Over the last few years, Juglone has been recognized for
its pharmacological properties by possessing antibacterial and antitumor properties.30
Additionally, Juglone has been characterized as a chemotherapeutic agent against cancers
for its capability of inducing apoptosis to human breast cancer cells, colon cancer cells,
and ovarian cancer cells.31 Figure 3 shows that upon irradiation of visible light to a
solution of TMPyP and 1,5-DHN, there is a decrease in the absorption peaks at 301, 317,
and 331 nm during the reaction. The decrease of the absorption of 1,5-DHN indicates that
it was reacting with singlet oxygen and producing Juglone which is known to absorb
around 423 nm. The Soret band of TMPyP and the absorption maximum of Juglone both
appear at 420 nm25 and 423 nm, respectively, which is why the increase of Juglone
absorption at 423 nm is not observed upon irradiation of TMPyP and 1,5-DHN solution.
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Figure 3: Photooxidation of DHN (1.2 × 10-4 M) by TMPyP (6.0 × 10-6 M) in aerobic
aqueous solution. Absorptions measured at 0 minutes of irradiation (blue color line), 2
minutes (orange color line), 4 minutes (light grey color line), 6 minutes (yellow color
line), 8 minutes (light blue color line), 10 minutes (green color line), 12 minutes (Navy
blue color line), 14 minutes (maroon color line), 16 minutes (dark grey color line), 18
minutes (brown color line), and 20 minutes (teal color line) minutes.

Another component of the multifunctional solution is iron. As an essential
nutrient in the human body, iron helps manage many functions which include
metabolism, growth in mammalian cells, and playing a role in heme by binding oxygen to
oxygenate tissues in the body. Conversely, iron is a transition metal which can accept or
lose electrons and take part in free radical formation reactions.32 Iron was also studied for
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its effects on the photooxidation of 1,5-DHN. Figure 4 portrays that the rate of
photooxidation of 1,5-DHN by TMPyP was variable by the concentrations of Fe(III) ions
in solution. The rate of photooxidation of 1,5-DHN by TMPyP, with various amounts of
Fe(III) ions, was monitored at 301 nm and was observed to follow pseudo first order
kinetics. The rate constants were calculated by linear regression fitting of the
experimental data (calculated absorbance values as ln(A0)/(A) vs t, where A0 is the
absorbance at time 0, and A is the absorbance at time (t)). The summary of all rate
constants of the photooxidation of 1,5-DHN by TMPyP as a function of the concentration
of Fe (III) ions is shown on Table 1. Without the presence of Fe (III) ions, the
photooxidation of 1,5-DHN by TMPyP had a rate constant of 6.58 × 10-4 s-1. With the
addition of 10 µL of 1.0 × 10-3 M Fe (III), the rate of the photooxidation of DHN did not
initially increase (k = 3.90 × 10-4 s-1) when compared to the metal free solution. However,
increases to the rate were observed when additional amount of Fe(III) ions was added in
increasing amounts. By the addition of 75 µL of 1.0 × 10-2 M of Fe(III) ions, the rate of
photo-oxidation of 1,5-DHN by TMPyP reduced (k = 5.68 × 10-4 s-1). Thus, to find an
optimum concentration for Fe(III) ions, to be a component of the multifunctional solution
with DHN (1.2 × 10-4 M) and TMPyP (6.0 × 10-6 M), a series of reactions were carried
out with Fe (III) ion concentrations ranging from approximately 15 µL of 1.0 × 10-2 M to
50 µL of 1.0 × 10-2 M. The maximum observed rate of photooxidation of 1,5-DHN by
TMPyP was when Fe(III) ion concentration was about 50 µL of 1.0 × 10-2 M (k = 9.43 ×
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10-4 s-1). Thus, as a component of the multifunctional solution, 1.0 × 10-4 M Fe(III) would
be used for all photooxidation studies.

Figure 4: The calculated absorbance of DHN (ln(A0)/(A)) monitored at 301 nm as a
function of irradiation time in the presence of DHN (1.2 × 10-4 M) and TMPyP (6.0 × 106
M) (blue circles); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and Fe(III) ions (1.0 ×
10-4 M) (dark green diamonds); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and Fe(III)
ions (5.0 × 10-5 M) (orange squares); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and
Fe(III) ions (3.0 × 10-5 M) (red triangles); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M),
and Fe(III) ions (1.5 × 10-4 M) (purple triangle); TMPyP (6.0 × 10-6 M), DHN (1.2 × 104
M), and Fe(III) ions (4.0 × 10-6 M) (yellow square); and TMPyP (6.0 × 10-6 M), DHN
(1.2 × 10-4 M), and Fe(III) ions (2.0 × 10-6 M) (light green diamonds) in aerobic aqueous
solution.
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Table 1. Summary of rate constants of DHN photo-oxidation by TMPyP as a function of
[Fe (III) ions] in aerobic conditions.

With all three components of the multifunctional solution, an effort to find the
nature of produced ROS was made by carrying out a series of control reactions. Similar
to previous experiments, Figure 5 shows the photooxidation of 1,5-DHN by
TMPyP/Fe(III) ions and was found to be increased dramatically in D2O solvent compared
to H2O which indicates the presence of singlet oxygen. However, for these sets of
experiments, a Rayonet photoreactor was used instead of a laser. Again, a significantly
slower photooxidation 1,5-DHN by TMPyP/Fe(III) ions was observed in the presence of
a physical quencher of singlet oxygen, NaN3.
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Figure 5: The rate of change of DHN monitored at 301 nm as a function of irradiation
time. Experiments were conducted in the presence of DHN (1.2 × 10-4 M), TMPyP (6.0 ×
10-6 M), and NaN3 (100 mM) (Red cross); DHN (1.2 × 10-4 M), TMPyP (6.0 × 10-6 M),
and D2O (Blue circle); DHN (1.2 × 10-4 M), TMPyP (6.0 × 10-6 M), and Iron (1.0 × 10-4
M) (orange square); and DHN (1.2 × 10-4 M), TMPyP (6.0 × 10-6 M), and H2O (Black
triangle)

Although singlet oxygen seemed to be the prime ROS, experiments were carried
out to determine if hydroxyl radicals (ȮH) could also be photooxidizing 1,5-DHN by
TMPyP/Fe (III) ions. These experiments were carried out in the presence of a hydroxyl
radical quencher, 2-propanol. Studies have indicated that 2-propanol reacts very quickly
hydroxyl radicals (1.3 × 10-9 M-1s-1)33 and produces 2-propanone as a product which can
be detected by GC-MS sepctrometry34. A series of experiments were carried out with an
excess of 2-propanol to verify the production of hydroxyl radical. The photooxidation of
1,5-DHN by TMPyP/Fe (III), in the presence of 2-propanol, was qualitatively analyzed
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through GC-MS data which indicated that the photo-induced generation of ROS was able
to convert 2-propanol to its principal oxidation product, 2-propanone in the presence of
1,5-DHN. Further experimentation showed that without the presence of 1,5-DHN, the
TMPyP/Fe(III) solution was incapable of producing 2-propanone in the presence of
visible light which indicated that 1,5-DHN needed to be present. This data shows that
with all three components of the multifunctional solution present, it can form singlet
oxygen and hydroxyl radicals in an aqueous solution, with visible light irradiation, and
aerobic condition.
Since iron can be present in different oxidation states and also be covalently
bonded to the core of a porphyrin ring, a few experiments were carried out to test the
photooxidation effects of 1,5-DHN by TMPyP and different irons. Figure 6 shows a
comparison of the rates of the photooxidation of 1,5-DHN by TMPyP/Fe(III),
TMPyP/Fe(II), and Fe(III)TMPyP (where the iron is covalently bonded to the center of
porphyrin ring) in an aqueous and aerobic condition. Table 2 contains the rate constants
for each experiment and they are as follows: 2.2 × 10-5 s-1 for TMPyP with Fe(II), 5.5 ×
10-5 s-1 for Fe(III)TMPyP, and 1.1 × 10-4 s-1 for TMPyP with Fe(III) ions. TMPyP and
Fe(III) ions shows a rate that is 2 times faster than Fe(III)TMPyP. With all things
considered, Fe (III)/1,5-DHN/TMPyP has shown characteristics for being a potential
therapeutic solution which is capable of producing singlet oxygen, hydroxyl radicals, and
Juglone or its derivatives under visible light and aerobic conditions. These special
characteristics can be applied to superficial cancer treatments or cancers where the target
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is able to be irradiated with visible light and has the presence of molecular oxygen. In
addition, the formation of Juglone and its derivatives from the multifunctional solution
also possesses anticancer and antimicrobial activity29 which can potentially kill target
cells as well.

Figure 6: The rate of change for DHN (1.2 × 10-4 M) peak at 301 nm when irradiated
with 20 minutes of light in solutions with Fe(III)TMPyP (6.0 × 10-6 M) (blue square);
TMPyP (6.0 × 10-6 M) and iron (II) (1.0 × 10-4 M) (red circle); and TMPyP (6.0 × 10-6
M) and iron (III) (1.0 × 10-4 M) (black triangle) in aerobic, aqueous solution.
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Table 2: Rates of photooxidation of DHN (1.2 × 10-4 M) monitored at 301 nm as a
function of irradiation time in the presence of Fe TMPyP (6.0 × 10-6 M), TMPyP (6.0 ×
10-6 M) and iron (II) (1.0 × 10-4 M), and TMPYP (6.0 × 10-6 M) and iron (III) (1.0 × 10-4
M), respectively, in aerobic aqueous solution. kobs is the rate constant (s-1) of the DHN
decay kinetics.

Generation of Hydroxyl radical (ȮH) and Juglone by the Multifunctional solution in
Anaerobic Condition with Visible Light Irradiation.
Since tumor hypoxia poses as a threat to the effectiveness of PDT, the
multifunctional solution was tested for its ability to generate ROS in anaerobic
conditions. Prior literature shows that for porphyrins with metals such as Fe(III) and
Mn(III), covalently bonded to the core of the porphyrin, have to capability to undergo a
photoreduction process to generate hydroxyl radicals in aqueous solution.35 Although the
mechanism is not well understood, Equation 2 shows the possible intramolecular
rearrangement for the generation of hydroxyl radicals by Fe(III) and Mn(III) porphyrins
under light conditions.

𝐹𝑒(𝐼𝐼𝐼)(𝑃𝑜𝑟)(𝑂𝐻)

→hν

𝐹𝑒(𝐼𝐼)𝑃𝑜𝑟 + Ȯ𝐻

24

𝐸𝑞. 2

To determine if the multifunctional solution could produce hydroxyl radicals in
anaerobic conditions, Fe(III)/1,5-DHN/TMPyP was thoroughly purged with argon and
the irradiated with visible light. For continuity, this solution was also compared to
Fe(II)/1,5-DHN/TMPyP and Fe(III)TMPyP (where the iron is covalently bonded to the
center of porphyrin ring) to determine if a difference in iron can affect the reaction. The
absorption of 1,5-DHN at 301 nm was recorded every 2 minutes to monitor its
degradation. Scheme 2 depicts a proposed reaction of how 1,5-DHN could interact with
hydroxyl radicals to produce Juglone or its derivatives.36 Figure 7 shows the comparison
rates of photooxidation of 1,5-DHN by TMyP/Fe(III), TMPyP/Fe(II), and Fe(III)TMPyP
in anaerobic aqueous conditions. Similar to aerobic conditions, the photooxidation of 1,5DHN by TMPyP/Fe(III) (k = 1.12 × 10-4 s-1) was approximately two times faster when
compared to the Fe(III)TMPyP solution (k = 5.50 × 10-5 s-1). Moreover, the rate of
photooxidation for 1,5-DHN was observed to be approximately five times slower in the
TMPyP/Fe(II) solution (k = 2.17 × 10-5 s-1) when compared to TMPyP/Fe(III).
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Scheme 2. The proposed reactions of hydroxyl radicals and DHN with the formation of
Juglone and Juglone derivatives.
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Figure 7: The rate of change for DHN (1.2 × 10-4 M) peak at 301 nm when irradiated
with 20 minutes of light in solutions with Fe(III)TMPYP (6.0 × 10-6 M) (blue square);
TMPYP (6.0 × 10-6 M) and iron (II) (1.0 × 10-4 M) (red circle); and TMPYP (6.0 × 10-6
M) and iron (III) (1.0 × 10-4 M) (black triangle) in anaerobic, aqueous solution.

Again, similar to the aerobic condition, the concentration of Fe(III) ions was
varied to study its influence on the photooxidation of 1,5-DHN, but now in anaerobic
conditions. As shown on Figure 8, 1,5-DHN showed negligible photooxidation when
Fe(III) ions were absent in the TMPyP solution. Unlike the aerobic condition, this data
indicated that TMPyP alone is not able to produce ROS in anaerobic conditions and even
when irradiated with visible light. However, with Fe(III) ions present with TMPyP, there
is clear evidence of photooxidation of 1,5-DHN without the presence of oxygen. Figure 9
shows the rate of changes of the photooxidation of 1,5-DHN by TMPyP in various
different concentrations of Fe(III) ions. For these experiments, the degradation of the
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absorption of 1,5-DHN was observed to obey pseudo first order decay kinetics, so the
rate constants were calculated from the slope of the experimental data (calculated
absorbance values as ln(A0)/(A) vs t, where A0 is the absorbance at time 0, and A is the
absorbance at time t). Table 3 shows a summary of the rate constants for each trial of
varying concentrations of Fe(III). The maximum rate (1.90 × 10-4 s-1) was achieved upon
addition of 50 µL of 1.0 × 10-2 M of Fe(III). However, upon addition of 75 µL of 1.0 ×
10-2 M of Fe (III) ions (k = 1.13 × 10-4 s-1), the rate constant of the photooxidation of 1,5DHN began to slow down in solution

Figure 8: The change in the absorbance peak (301 nm) of DHN (1.20 × 10-4 M) in an
anaerobic aqueous solution of just TMPYP (6.0 × 10-6 M) (black triangle) and an
anaerobic aqueous solution of TMPYP (6.0 × 10-6 M) and iron (III) (1.0 × 10-4 M) (red
circle)
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Figure 9: The calculated absorbance of DHN (ln(A0)/(A)) monitored at 301 nm as a
function of irradiation time in the presence of DHN (1.2 × 10-4 M) and TMPyP (2.8 × 106
M) (black circles); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and Fe(III) ions (2.0 ×
10-6 M) (purple diamonds); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and Fe(III) ions
(4.0 × 10-6 M) (green squares); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and Fe(III)
ions (3.0 × 10-5 M) (empty triangles); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M), and
Fe(III) ions (5.0 × 10-5 M) (orange squares); TMPyP (6.0 × 10-6 M), DHN (1.2 × 10-4 M),
and Fe(III) ions (1.0 × 10-4 M) (blue diamonds); and TMPyP (6.0 × 10-6 M), DHN (1.2 ×
10-4 M), and Fe(III) ions (1.5 × 10-4 M) (red triangles) in anaerobic aqueous solution.
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Table 3. Summary of all the rate constants for the photooxidation of DHN by TMPyP as
a function of [Fe (III) ions] in anaerobic conditions.

To confirm that the ROS being produced were hydroxyl radicals, a series of
control reactions for the multifunctional solution were carried out in when irradiated with
visible light in anaerobic conditions. The first experiment consisted of purging
Fe(III)/1,5-DHN/TMPyP with argon and testing for its capability of generating oxygen
gas, which was monitored by an oxygen meter, for more than two hours of irradiation
with visible light. This experiment showed no sign of oxygen gas production, so there is
no possibility for the ROS to be singlet oxygen because its production requires the
presence of oxygen. Even with the presence of a photosensitizer and visible light, there
could not be any production of singlet oxygen. Therefore, the ROS is believed to be
something other than singlet oxygen. To further verify the absence of singlet oxygen,
similar photosensitization experiments were carried out in D2O solvent. When compared
to the experiment using H2O as the solvent, there was no evidence of an increase in the
rate of photooxidation of 1,5-DHN.
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With no singlet oxygen present in anaerobic conditions, the next possible ROS
that was tested for was hydroxyl radicals. Similar 1,5-DHN photooxidation reactions
were carried out in an anerobic environment using TMPyP/Fe(III) ions and in the
presence of excess 2-propanol. Qualitative GC-MS analysis indicated that 2-propanol
was converted to 2-propanone as an oxidized product. Interestingly, like previous results,
no 2-propanone was detected by GC-MS analysis when the argon purged solution did not
contain 1,5-DHN. Again this data indicated that all three components, 1,5DHN/TMPyP/Fe(III), must be present for the production of hydroxyl radicals in
anaerobic aqueous environment. The discovery that the multifunctional solution has the
ability to produce hydroxyl radicals in anaerobic conditions is remarkable and may serve
as a new PDT treatment option for hypoxic tumors.

Detoxification of H2O2 with Production of Hydroxyl Radicals and Juglone by
Multifunctional Solution in the Absence of Visible Light.
Producing ROS without the presence of visible light is a major limitation of PDT
since photosensitizers depend on visible light to convert dissolved oxygen to singlet
oxygen. PDT is ineffective when tumors are deep in the body and light delivery systems
have difficulty reaching the organ/tissue. Moreover, if the tumor is too large, then the
light delivery systems also face the challenge of not being strong enough to penetrate the
tumor. Since tumor cells are often hypoxic, another issue for PDT therapy is the lack of
oxygen available to create singlet oxygen. Fenton reactions utilizing Fe(II) in the
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presence of hydrogen peroxide have been shown to produce hydroxyl radicals without
irradiation of visible light. Therefore, hydrogen peroxide was added to the
multifunctional solution to test its ability to produce hydroxyl radicals in a Fenton-like
reaction. Like other experiments, different oxidation states of iron were used, as well as
iron that was coordinated to the center of TMPyP’s porphyrin ring. Figure 10 shows the
oxidation of 1,5-DHN by TMPyP/Fe(III), TMPyP/Fe(II), and Fe(III)TMPyP with
increasing microliter amounts of hydrogen peroxide under dark conditions. Specifically, a
higher rate of 1,5-DHN is observed with TMPyP/Fe(III) and Fe(III)TMPyP when
compared to the TMPyP/Fe(II) ions. Scheme 3a presents a standard Fenton-like reaction
where hydrogen peroxide reacts with Fe(III) ions and forms a Fe(III)-peroxo complex
that later decomposes into Fe(II) and hydroperoxyl radicals. This produced Fe(II) ions
can further react with hydrogen peroxide to generate hydroxyl radicals through a standard
Fenton reaction (Scheme 3b). Interestingly, the produced hydroperoxyl radicals can react
with the following: Fe(III) ions, Fe(II) ions, or other hydroperoxyl radicals to produce
oxygen gas and Fe(II), Fe(III)-peroxo complex, or oxygen gas alone, respectively.37 This
aspect of the Fenton and Fenton-like reactions could be extremely advantageous for
treating cancer cells. Although these preliminary results require the addition of hydrogen
peroxide to be effective in dark conditions, reports in literature have shown that cancer
cells produce more hydrogen peroxide than normal cells due to their characteristics of
abnormal cellular proliferation.38 Normally, an enzyme called catalase has the vital
protective role of preventing the buildup of hydrogen peroxide by converting it to water
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and oxygen.38 However, physiological concentrations of catalase are not sufficient
enough to detoxify the increased amounts of hydrogen peroxide produced which has been
shown to leave many cells without efficient protection and can actually increase the
progression of cancer cells.39-40 Remarkably, this reaction of the multifunctional
composition with hydrogen peroxide suggests that the Fenton-like reaction can generate
hydroxyl radicals and, at the same time, oxidize 1,5-DHN without the presence of visible
light to form Juglone or its derivatives. In addition, oxygen gas that is produced from
these Fenton-like reactions could also play a role in eliminating hypoxic environments
which will help increase the effectiveness of PDT. As a control, 1,5-DHN with TMPyP
showed no oxidation with increased concentrations of hydrogen peroxide. In addition,
1,5-DHN alone showed no observable signs of being oxidized in the presence of
hydrogen peroxide. This data suggest that Fe(III) ions and hydrogen peroxide are the
required reagents for the generation of hydroxyl radicals in aqueous solution.
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Figure 10: The rate of change for DHN (1.2 × 10-4 M) peak at 301 nm when 1.0 × 10-6 M
H2O2 is added to the solution of Fe(III)TMPYP (6.0 × 10-6 M) (blue square); TMPYP
(6.0 × 10-6 M) and iron (II) (1.0 × 10-4 M) (red circle); and TMPYP (6.0 × 10-6 M) and
iron (III) (1.0 × 10-4 M) (black triangle) in aerobic, aqueous solution under dark
conditions.

To improve the benefits of the Fenton-like reaction for producing hydroxyl
radicals in aqueous and dark conditions, an experiment was implemented to determine an
optimum concentration for hydrogen peroxide and Fe(III) ions. Figure 11a is an
experiment where the concentrations of 1,5-DHN (1.2 × 10-4 M), TMPyP (6.0 × 10-6 M),
and Fe(III) (1.0 × 10-4 M) were kept constant and varying amounts of hydrogen peroxide
were added. Figure 11a shows that a maximum decrease in the absorption of 1,5-DHN, at
301 nm, was observed when 400 μM of hydrogen peroxide was added. In addition,
Figure 11b shows the difference in the absorption of 1,5-DHN when in the presence of 50
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μM and 400 μM of hydrogen peroxide which were the lowest and optimal concentrations
tested, respectively.

Figure 11: (a) Optimization of H2O2 concentration in the presence of 1 × 10-4 M iron
(III) in aerobic, aqueous solution under dark conditions. (b) The UV-vis spectra of the
recorded optimum H2O2 concentration at 400 μM.
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In contrast, a similar experiment was carried out to find the optimum
concentration of Fe(III) ions by varying its concentration when TMPyP, 1,5-DHN, and
hydrogen peroxide (400 μM) are kept constant. Figure 12a depicts the changes in the
absorption of 1,5-DHN at 301 nm with varying concentrations of Fe(III) ions. In this
figure, there is a maximum decrease in 1,5-DHN’s absorption when a concentration of 25
μM is used for Fe(III) ions (see Figure 12b for full spectrum of 1,5-DHN’s oxidation in
presence of 25 μM of Fe(III) ions).
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Figure 12: (a) Optimization of iron (III) concentration in the presence of 400 μM iron
(III) in aerobic, aqueous solution under dark conditions. (b) The UV-vis spectra of the
recorded optimum iron (III) concentration at 25.0 μM.
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To our surprise, when higher concentrations of Fe(III) ions (1.0 × 10-2 M) and
hydrogen peroxide (1.0 × 10-2 M) were used with TMPyP and 1,5-DHN, oxygen gas
bubbles could be visually observed in the solution at room temperature under normal
atmospheric conditions (Figure 13a). This visual generation of oxygen gas was confirmed
using an oxygen meter and was found to be dependent on high concentrations of Fe(III)
and hydrogen peroxide, as previous experiments did not produce oxygen gas that could
be seen visually. Interestingly, when Fe(III)TMPyP was placed in high concentrations of
hydrogen peroxide, there was brown sludge precipitate of Fe(OH)3 which was not present
in the Fe(III)/1,5-DHN/TMPyP mixture (Figure 14). For each experiment, the pH before
and after the experiment was recorded. The pH of the solution would begin at 5.5 and
gradually decrease to 3.0 upon addition of hydrogen peroxide. This change in pH
suggests that, upon reaction of Fe(III) with hydrogen peroxide, oxygen gas is produced
with a release of protons into the solution as described previously on Scheme 3b. In short,
it appears that the multifunctional treatment composition has the capability of detoxifying
excess hydrogen peroxide to oxygen gas which can partially help alleviate hypoxic
environments and potentially decrease the progression of cancer cells. Moreover, without
the presence of visible light, the multifunctional treatment solution can still produce
hydroxyl radicals and Juglone and its derivatives to potentially kill cancer cells (Scheme
3c).
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Figure 13: (a) Oxygen gas generation in an aqueous iron (III) (1.0 × 10-2 M) and H2O2
(1.0 × 10-2 M).; (b) Oxygen gas measured by oxygen electrode in mV vs time (min).
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Figure 14: Dark precipitate in solution with Fe TMPyP (5.71 × 10-6 M), DHN (1.14 ×
10-4 M) and H2O2 (1.0 × 10-1 M) after 18 hours.
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Scheme 3. (a) Possible reactions from Fenton-like reaction, (b) possible reactions from
HȮ2, and (c) possible reactions from ȮH.
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Fluorescence Study of the Multifunctional Treatment Composition and its
Components.
Figure 15 depicts the emission spectra of TMPyP in aqueous solution which has a
maximum at 657 nm when excited at 423 nm. Several experiments were carried out to
determine how the intensity of TMPyP changes with the addition of the Fe(III) ions and
1,5-DHN. When the Fe(III) ions were added to the TMPyP solution, the fluorescence
intensity of the solution showed negligible changes. However, with the addition of 1,5DHN to the TMPyP and Fe(III) ions mixture, there appeared to be a slight decrease to the
intensity.
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Figure 15. Emission spectra for TMPyP, iron (III), and DHN in aqueous solution. The
blue line is 6.0 × 10-6 M TMPyP alone. The orange line is 6.0 × 10-6 M TMPyP with 1.0
× 10-4 M iron (III). The grey line is 6.0 × 10-6 M TMPyP, 1.0 × 10-4 M iron (III), and 1.2
× 10-4 M DHN. Each sample recorded was ran using the following parameters: Ex
WL:423 nm; Start:433 nm; End:800 nm; Ex Slit:10.0 nm; Em Slit:12.0 nm; Speed:1000
nm/min; Gain: High; Auto Lamp: on
The fluorescence quantum yield (ΦF) of TMPyP was calculated using Equation 3
while crystal violet (1.0 × 10-5 M) was used as a standard with a known fluorescence
quantum yield of 0.020 in water.41

𝛷𝐹(𝑥)

𝐴𝑠 𝐹𝑥
𝑛𝑥 2
= 𝛷𝐹(𝑠) ×
× ×( )
𝐴𝑥 𝐹𝑠
𝑛𝑠

𝐸𝑞. 3

For this equation, A represents the absorbance, while F represents the area under the
emission’s curve, and where n is the refractive index of the solvent used. Upon
calculation, the fluorescence quantum yield of TMPyP was observed to be 0.0139.
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Current literature shows the fluorescence quantum yield to be 0.016.42 This data indicates
that TMPyP can fluoresce in aqueous media with only minor decreases to its fluorescence
intensity when Fe(III) ions and 1,5-DHN is present.

In vitro effects of the Multifunctional Treatment Composition, Under Visible Light
Irradiation, on BL21 E. coli in Aerobic Conditions.
The first stage of in vitro cell growth studies included testing the multifunctional
solution on E. coli bacteria to determine its efficacy in stopping or slowing the
progression of E. coli cell growth as a treatment composition. Several trials with various
chemical combinations were conducted. Table 4 shows the survival of E. coli when
treated with (a) 1,5-DHN, (b) Juglone, (c) TMPyP/Fe(III), (d) TMPyP/1,5-DHN, and (e)
TMPyP/1,5-DHN/Fe(III) ions in the absence and presence of light.

Table 4. Survival of Escherichia coli in the presence of DHN, Juglone, Fe (III), and
TMPyP with various combinations.
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Figure 16a shows the experimental trial of 1,5-DHN (1.2 × 10-4 M) in the absence and
presence of light which showed no inhibition (0 %) of growth of E. coli. Since Juglone is
the photooxidized product of 1,5-DHN and is also known for its antibacterial and
anticancer activity, Juglone was tested against E. coli which can be seen on Figure
16b.29,43 This data shows that Juglone has complete inhibition (99.99 %) of growth when
treated in dark or in the presence of visible light. Figure 16c shows a solution of
TMPyP/Fe(III) ions which showed 0 % inhibition of growth in E. coli cells during dark
conditions. This specific chemical combination suggests that it is non-toxic to the E. coli
cells when not irradiated with visible light. However, in the presence of visible light,
there was near complete inhibition (~100 %) of E. coli growth (Figure 16c). This data is
clear that reactive oxygen species, mainly singlet oxygen, is produced from the
photosensitization of TMPyP. Similarly, 100 % inhibition of growth was observed when
TMPyP/1,5-DHN was reacted with E. coli solution under visible light, and interestingly
this solution showed significant inhibition (~99.99 %) in the absence of light (Figure
16d). The mechanism for how TMPyP/1,5-DHN inhibits E. coli cells in dark is not quite
well understood. Finally, the multifunction treatment composition, TMPyP/1,5DHN/Fe(III) ions, was tested against the E. coli. In the presence of light and absence of
light, the multifunctional treatment composition showed a complete inhibition (100 %) of
growth and significant inhibition (~99 %), respectively. Lastly, since the oxidized
product of 1,5-DHN is Juglone, a separate experiment was carried out to determine if
TMPyP/Juglone/Fe(III) ions could slow or stop E. coli cell growth. Figure 16f shows that
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there is a complete inhibition of E. coli growth when this treatment is in the presence of
light and without light. In short, this data suggests that TMPyP/1,5-DHN/Fe(III) solution
can produce ROS and Juglone or its derivatives which can be used to kill E. coli cells in
the presence of visible light. Furthermore, the multifunctional solution is a promising
solution that can potentially stop or slow the progressions of E. coli.
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Figure 16. E. coli growth monitored after 48 hours, with (a) 1.2 × 10-4 M DHN (b) 1.2 ×
10-4 M Juglone (c) 6.0 × 10-6 M TMPyP and 1.0 × 10-4 M Fe (III) (d) 6.0 × 10-6 M
TMPyP and 1.2 × 10-4 M DHN (e) 6.0 × 10-6 M TMPyP, 1.2 × 10-4 M DHN, and 1.0 × 104
M iron (III) (f) 6.0 × 10-6 M TMPyP, 1.2 × 10-4 M Juglone, and 1.0 × 10-4 M iron (III).
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In vitro effects of the Fenton-like reactions on BL21 E. coli in the Absence of Visible
Light.
The first stage of in vitro studies was expanded by including hydrogen peroxide
rich environments to determine if it has potential to be effective against E. Coli cells and
be part of the multifunctional treatment composition’s unique characteristics. As stated
previously in Scheme 3a, in Fenton-like reactions, Fe(III) ions and hydrogen peroxide
can produce ROSs such as hydroxyl radicals and hydroperoxyl radicals. Since these ROS
are known for killing bacteria such as E. Coli, the Fenton-like reactions were examined.
In particular, E. Coli was mixed with hydrogen peroxide in dark conditions and in room
temperature. Figure 17 depicts a significant inhibition of growth of E. coli when 1.0 × 104

M Fe(III) ions and 400 μM H2O2 were used together. As a control, Fe(III) ions at a

concentration of 1.0 × 10-4 M and 1.0 × 10-3 M Fe(III) was used alone to determine if it
was toxic to the E. Coli cells. In similar fashion, 400 μM of hydrogen peroxide alone was
also used as a control. In short, there was no inhibition of growth in the bacteria when the
Fe(III) ions and hydrogen peroxide were administered alone. However, when 400 μM of
hydrogen peroxide and 1.0 × 10-3 M Fe(III) were used, the results showed nearly a
complete inhibition of E. Coli. These observations indicate that the multifunctional
treatment solution will be able to produce ROS and kill bacteria and potentially cancer
cells in dark when hydrogen peroxide is present.
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Figure 17: E. coli growth, monitored after 48 hours, with (a) 1 × 10-4 M Fe (III) (b) 1 ×
10-3 M Fe (III) (c) 400 μM H2O2 (d) 1 × 10-4 M Fe (III) and 400 μM H2O2 (e) 1 × 10-3 M
Fe (III) and 400 μM H2O2.
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In vitro effects of the Multifunctional Treatment Composition on MCF-7 Breast
Cancer Cells.
The positive results from the E. Coli experiments led to a new set of experiments
which was to test the multifunctional treatment solution on MCF-7 breast cancer cells.
Approximately 10,000 cells/well were treated with a combination of TMPyP at 6.0 × 10-6
M, 1,5-DHN at 1.2 × 10-4 M, and Fe(III) ions at 1.0 × 10-4 M under normal room
temperature and pressure. Table 5 shows a summary, in percentage, of MCF-7 cell
survival after being treated with a single dose of the multifunctional treatment solution.
For each experiment, the cells were either exposed to visible light or left in dark for 10
minutes. TMPyP alone is capable of producing singlet oxygen in the presence of visible
light and was able to kill 22 % of MCF-7 cells when irradiated by visible light. In
contrast, in dark, TMPyP was only able to kill approximately 1.6 % of the cells (Table 5).
Through the presence of Fe(III) ions alone, there was approximately 4 % inhibition of
MCF-7 cells with visible light present. Lastly, with 1,5-DHN present alone with visible
light, there was nearly 13 % of inhibition of cell growth. However, when all components
were added together there was a considerable amount of inhibition, approximately 52 %,
when the composition was in the presence of visible light for about 10 minutes. When the
concentration of the treatment composition increased, there was an increase in inhibition
of cell growth. These results indicated that the treatment composition was dose
dependent. Moreover, a separate experiment showed that if the treatment did not continue
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after 10 minutes of visible light irradiation, then the cells were able to grow back and
divide within 24 to 48 hours.
Table 5. Percent survival of 10,000 MCF-7 cells in 10 minutes of light and dark
condition where each trial’s cell viability was measured immediately after treatment.

In contrast, similar experiments were carried out but in the absence of visible light to
determine if there were any therapeutic effects of the multifunctional treatment solution
on MCF-7 breast cancer cells. Similar to the visible light results, the three components,
TMPyP, Fe(III) ions, and 1,5-DHN, were used separately and showed little to no
inhibition of growth when in the absence of visible light. Interestingly, when all
components were placed together, there was only minimal cell death, approximately 3 %,
when compared to the control in dark. More investigation and additional repeats of the
experiments are needed to further confirm these results. However, it is possible that the
cancer cells contained a low concentration of hydrogen peroxide which only produced
minimal ROS or Juglone and its derivatives to treat the cells which could explain why
there was only slight inhibition of cell growth.
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CHAPTER 4

Conclusion

In conclusion, the multifunctional treatment solution is comprised of TMPyP, 1,5DHN, and Fe(III) ions. Each component has a specific role and is pertinent for
overcoming several limitations of PDT. In an aerobic environment, TMPyP is able to
produce singlet oxygen, hydroxyl radicals, and Juglone or its derivatives under visible
light irradiation. The addition of Fe(III) ions were shown to increase the rate of
photooxidation of 1,5-DHN when compared to the addition of Fe(II) ions and Fe(III)
coordinated to the porphyrin ring. Under anaerobic conditions, TMPyP alone is only
minimally able to photooxidize 1,5-DHN. Without the presence of oxygen, singlet
oxygen is unable to be generated which poses as a major limitation for PDT. However,
with the addition of Fe(III) ions, the photooxidation of 1,5-DHN is observed and is faster
than Fe(II) ions and Fe(III)TMPyP where Fe(III) is coordinated to the center of the
porphyrin. Moreover, Fenton-like reactions were utilized because the Fe(III) component
of the multifunctional treatment solution has the ability to react with hydrogen peroxide
that is produced from cancer cells. An optimum concentration of 25 µM Fe(III) reacted
with 400 µM hydrogen peroxide to produce hydroxyl radicals, Juglone, and oxygen gas
(O2) in the absence of visible light and without forming Fe(OH)3 sludge. This remarkable
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ability has potential to treat tumors that are unable to be penetrated, deep in tissues, by
visible light which is another limitation of PDT. In addition to the multifunctional
treatment solution’s potential in anticancer ability, this treatment solution also has
potential in containing antibacterial properties. The composition was observed to inhibit
the growth of E. coli in the presence of light, hydrogen peroxide, and dark conditions.
Lastly, we investigated the treatment solution against MCF-7 breast cancer cells in vitro
and observed that the solution can partially inhibit the growth of breast cancer cells.
However, further studies and experimentations are needed against a variety of cancer cell
lines to observe the true potential of the multifunctional treatment composition.
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